Ngapas, Charmine C.

HRN: 18-58-72  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/26/2025
CEFUROXIME 500MG (TAB)
07/26/2025
08/02/2025
PO
500mg
BID
NSVD With 2nd Degree Laceration
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: